|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01501 INT MEDICAL
Nominal 
31.420 -0.960 (-2.965%) | 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Turnover | 461,075 | 17.525% | 392,322 | 339,764 | 225,217 | 180,613 |
| Cost of Sales | (190,414) | 30.820% | (145,554) | (139,414) | (101,194) | (64,677) |
| Gross Profit | 270,661 | 9.682% | 246,768 | 200,350 | 124,023 | 115,936 |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | 481 | (637) | (30) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (585) | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 120,707 | 8.992% | 110,749 | 88,417 | 56,829 | 59,864 | |
| Taxation | (18,271) | 57.903% | (11,571) | (7,912) | (6,704) | (8,570) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (3,908) | -- | 1,360 | (3) | 716 | (689) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 98,528 | -1.999% | 100,538 | 80,502 | 50,841 | 50,605 | |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Net Finance Costs / (Income) | (2,695) | -16.200% | (3,216) | (5,073) | (5,291) | (5,608) |
| Depreciation & Amortisation | 44,426 | 5.440% | 42,134 | 20,911 | 17,374 | 14,033 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| EPS (cts) | 57.000 | -1.724% | 58.000 | 48.000 | 31.000 | 30.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 10.659 | -- | 9.538 | 9.253 | 8.506 | 7.677 |
| Remarks: | Real time quote last updated: 12/09/2025 14:31 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 98,528 |
| %Change | -1.999% |
| EPS / (LPS) | RMB 0.570 |
| NBV Per Share (¥) | RMB 10.659 |